Connect with us
DAPA Banner
DAPA Coin
DAPA
COIN PAYMENT ASSET
PRIVACY · BLOCKDAG · HOMOMORPHIC ENCRYPTION · RUST
ElGamal Encrypted MINE DAPA
🚫 GENESIS SOLD OUT
DAPAPAY COMING

Business

Over 11,000 bottles of blood pressure medication recalled nationwide

Published

on

Over 11,000 bottles of blood pressure medication recalled nationwide

More than 11,000 bottles of blood pressure medication are being recalled nationwide due to a manufacturing defect, according to the Food and Drug Administration.

The 11,460 bottles of chlorthalidone tablets, USP, 25 mg, are being recalled because of “failed dissolution specifications.” 

Advertisement

Dissolution tests measure the release rate of a drug and its active ingredient from the tablet or capsule used as a dosage when it’s placed into a liquid to assess the performance and quality of various drug formulations and batches, according to pharmaceutical company Pion.

The recalled drugs were manufactured by Inventia Healthcare Limited of India – which initiated the voluntary recall – and distributed in the U.S. by Rising Pharma Holdings of East Brunswick, New Jersey.

500K PACKAGES OF MACARONI AND CHEESE SOLD AT ALDI RECALLED OVER UNDECLARED SOY LECITHIN

Prescription medication in hand.

The recalled chlorthalidone tablets failed dissolution specifications, according to the FDA. (Getty Images)

FOX Business reached out to Inventia Healthcare and Rising Pharma for comment.

Advertisement

The Cleveland Clinic said that chlorthalidone is used to treat high blood pressure by helping kidneys remove fluid and salt from a user’s blood through their urine.

It’s considered a diuretic drug and may also be used to reduce swelling related to heart, kidney or liver disease.

DEADLY LISTERIA OUTBREAK SPARKS EXPANDED CHEESE RECALL ACROSS MULTIPLE STATES

A pharmacy tech pulls medication from a shelf inside a pharmacy

Chlorthalidone is a diuretic that can be used to treat high blood pressure and to reduce swelling caused by heart, kidney or liver disease. (George Frey/Bloomberg via Getty Images)

The recall was initiated voluntarily by the company on June 5 and is ongoing, according to the FDA’s recall page.

Advertisement

It covers 25 mg chlorthalidone tablets sold in either 100 or 1000 tablets per bottle as prescribed by a doctor.

CDC URGES PARENTS TO STOP USING NARA ORGANICS INFANT FORMULA AFTER THREE BABIES HOSPITALIZED WITH BOTULISM

An image of medication at a Walgreens pharmacy.

The voluntary recall is ongoing and covers specific batches of the medication. (Jeffrey Greenberg/Universal Images Group via Getty Images)

The 100 tablet bottles covered by the recall have a batch code of RISA24001, while the 1000 tablet bottles have a batch code of RISB24002.

The expiration date for bottles covered by the recall is April 2027.

Advertisement

GET FOX BUSINESS ON THE GO BY CLICKING HERE

Continue Reading
Click to comment

You must be logged in to post a comment Login

Leave a Reply

Business

Talkspace chief legal officer John Reilly sells $209,514 in stock

Published

on


Talkspace chief legal officer John Reilly sells $209,514 in stock

Continue Reading

Business

Form 4 Talkspace Inc For: 22 June

Published

on


Form 4 Talkspace Inc For: 22 June

Continue Reading

Business

Global Market Today: Asian stocks dip at open as oil edges higher

Published

on

Global Market Today: Asian stocks dip at open as oil edges higher
Asian stocks opened lower as oil edged higher, with investors continuing to watch developments in US-Iran peace talks.

MSCI Inc.’s gauge of regional shares fell as much as 0.2% in early trading. S&P 500 futures also edged lower after a slide in megacap tech stocks and rising bond yields dragged the benchmark down 0.4% Monday. SpaceX shares slipped for a third straight day, shedding hundreds of billions of dollars in value. Brent crude prices rose slightly to trade above $78 a barrel.

The US issued a 60-day license allowing Iran to sell oil on the international market, giving Tehran an economic lifeline as the two adversaries are poised to continue discussions to reach a permanent peace deal.

Meanwhile, Vice President JD Vance described the first round of negotiations with Iran as “very, very good” and said Tehran had agreed to allow nuclear inspectors back into the country. But officials from the Islamic Republic, who also cited progress, challenged that claim, saying Vance’s assertion was “false and does not reflect reality.”

Advertisement

While geopolitical developments are likely to remain a key source of volatility in the near term, shifts in investor confidence regarding the durability of the AI rally may also lead to bouts of market swings, according to Ulrike Hoffmann-Burchardi at UBS Chief Investment Office.


Expectations that an agreement will be reached, as well as the revival of the AI trade and solid corporate earnings, have fueled a 14% advance in the S&P 500 Index this quarter. However, that trails the 26% surge in the MSCI Asia Pacific Index.
Treasuries fell on Monday as trading resumed following a US public holiday, even as oil prices turned lower Iran said there had been “major progress” in all-night discussions with the US. Strategists cited Federal Reserve Chairman Kevin Warsh’s hawkish messaging last week as one of the reasons for the selling pressure.In currency markets, the Japanese yen lingered near its lowest level since 1986 as investors weighed the prospects for a lasting US-Iran peace deal and the risk of intervention by Japanese authorities. The Bloomberg Dollar Spot Index was little changed after rising 0.2% on Monday.

SpaceX plunged 16% after saying it’s selling investment-grade bonds in what’s expected to be a massive borrowing spree. Its bond sale is the latest in a wave of deals from companies driving the AI boom. Alphabet, Amazon.com Inc. and others have raised more than $300 billion of debt tied to AI since November across multiple credit markets. The rocket firm is seeking to raise at least $20 billion, Bloomberg reported.

“The issue that stands out the most is the idea that the hyperscalers continue to receive an extremely low return on investment on their colossal level of spending on AI,” said Matt Maley at Miller Tabak. “Another big concern surrounds the issue of ‘circular investments,’ where companies invest in each other, while also committing to buying each other’s products.”

Elsewhere, Andy Burnham appears set to become the UK’s seventh prime minister in a decade after Keir Starmer laid out a timeline for his own departure and potential rivals backed a quick transition to the popular Manchester politician. While markets showed little reaction to the resignation, they were buoyed by reduced odds of a leadership contest that could have prolonged uncertainty.

Advertisement
Continue Reading

Business

BJ’s Restaurants director Ottinger sells $149,372 of common stock

Published

on


BJ’s Restaurants director Ottinger sells $149,372 of common stock

Continue Reading

Business

Oklo: Almost Everything Has Changed Since My Sell Call – Almost

Published

on

Oklo: Almost Everything Has Changed Since My Sell Call - Almost

Oklo: Almost Everything Has Changed Since My Sell Call – Almost

Continue Reading

Business

SpaceX falls for third day, erases $600 billion in market value

Published

on

SpaceX falls for third day, erases $600 billion in market value
SpaceX shares slipped for a third straight day, shedding hundreds of billions of dollars in market value, after the Elon Musk-led company said it is selling investment-grade bonds for the first time, part of what’s expected to be a massive borrowing spree to fund its artificial-intelligence ambitions.

The stock fell 16% Monday to close at $154.60, the lowest level since the company’s first day of trading, pushing its three-day loss to 23% and erasing over $600 billion in value over that period. The company’s market capitalization now sits just above $2 trillion.

“Sellers are back in control. Anyone in the world who wanted to buy this has bought it already,” said Michael O’Rourke, chief market strategist at JonesTrading.

SpaceX’s first days of trading following its record $75 billion initial public offering were met with the type of volatility generally associated with new IPOs that have a low float — 4.2% of total shares outstanding were available to trade on day one — and high interest from retail investors. Still, even with Monday’s losses, SpaceX is the sixth-largest company in the world with shares about 15% higher than their $135 IPO price.

Advertisement
458914698Bloomberg

The rocket, satellite and AI conglomerate is seeking to raise at least $20 billion from the first bond offering, Bloomberg reported last week. SpaceX also inked a multibillion-dollar agreement to provide computing resources to Reflection AI, an AI startup, the company said Monday.


SpaceX’s embrace of artificial intelligence with the acquisition of Musk’s xAI in February meant investors closely watched the listing ahead of IPO prospects of competitors Anthropic PBC and OpenAI, both of which plan to go public as soon as this year with valuations expected to be around $1 trillion.
Retail trading in SpaceX, officially named Space Exploration Technologies Corp., was the strongest of any IPO in recent history, with the cohort buying net $405 million in the first five sessions according to Vanda Research. Retail investors bought more SpaceX last week than buying across all Magnificent Seven stocks combined, the data showed. On Monday, retail traders were still net buyers of SpaceX, but inflows were below last week’s levels, Vanda data showed. The stock was initiated with a recommendation of sector weight at KeyBanc Capital Markets, the first hold-equivalent rating according to data tracked by Bloomberg. Analysts led by Michael Leshock wrote that SpaceX is set to remain the leader in space-launch and adjacent verticals, but much of the long-term value is already captured in the stock price.

SpaceX “possesses significant disruptive growth avenues, though we believe this is reflected in current valuation and risk/reward appears balanced, in our view,” he wrote.

Continue Reading

Business

Form 4 CrowdStrike Holdings Inc For: 22 June

Published

on


Form 4 CrowdStrike Holdings Inc For: 22 June

Continue Reading

Business

Should you be tracking your water level?

Published

on

Should you be tracking your water level?

His company is one of several that makes sweat-analysing devices. In Epicore Biosystems’ case, that includes single-use sticky patches and sleeve-like wearables, which track the flow rate of sweat as it emerges from your skin, the sweat’s sodium (salt) content, and skin temperature, among other metrics.

Continue Reading

Business

AST SpaceMobile: My Bet On The New Telecommunications Order

Published

on

AST SpaceMobile: My Bet On The New Telecommunications Order

AST SpaceMobile: My Bet On The New Telecommunications Order

Continue Reading

Business

Wall Street ends mixed as investors focus on Iran talks

Published

on

Wall Street ends mixed as investors focus on Iran talks

The S&P 500 and ‌the Nasdaq have closed down, dragged by declines in the megacap technology stocks including Alphabet.

Continue Reading

Trending

Copyright © 2025